Because liquid biopsy by NGS is able to provide the allele frequency (AF) of each mutated variant, we aimed to understand if the AF of PIK3CA and TP53 oncogenic mutations could be representative of total tumor burden. The gene discussed is TP53; the disease is neoplasm.